What happens when you stop taking a GLP-1
It’s the question people are most afraid to ask before they start, and the one most companies answer with a shrug. Here’s what the withdrawal trials actually found, why appetite comes back, and what genuinely changes how much of your progress you keep.
The short version
- Regain after stopping is common and well documented. Anyone who tells you otherwise is selling something.
- In the STEP 1 extension, people who stopped semaglutide regained about two-thirds of their lost weight over the following year — though they were still 5.6% below where they started.
- In SURMOUNT-4, those who switched off tirzepatide gained back a mean of 14% of body weight over 52 weeks, while those who continued lost a further 5.5%.
- Two things drive it at once: appetite signalling returns to its old setting, and a smaller body simply needs less energy.
- How much you regain varies a great deal, and the amount matters — people who held most of their loss also held most of their health improvements.
- Preserved muscle, established habits, a planned taper, and for many people a maintenance dose are what tilt the odds.
The straight answer.
If you stop a GLP-1 and change nothing else, weight typically comes back. Not always all of it, and not at the same rate for everyone — but on average, most of it.
We lead with that because you deserve to know it before you spend a dollar, not after. And because the version you’ll hear elsewhere tends to be one of two unhelpful extremes: either “you’ll be on this forever” or “our special plan means you won’t regain.”
Neither is true. The honest answer is more useful than either.
What the trials actually found.
Two large withdrawal studies give us the clearest picture. Both did the same basic thing: treat people for a while, then take the medication away and watch.
| Study | On treatment | After stopping |
|---|---|---|
| STEP 1 extension semaglutide 2.4 mg |
Mean loss of 17.3% of body weight at 68 weeks | Regained 11.6 percentage points over the next year — roughly two-thirds of what was lost. Net still 5.6% below starting weight. |
| SURMOUNT-4 tirzepatide |
Mean loss of 20.9% over a 36-week lead-in | Those switched to placebo gained a mean 14.0% of body weight over 52 weeks. Those who continued lost a further 5.5%. |
One detail from SURMOUNT-4 is worth sitting with: about 9 in 10 people who continued treatment held onto at least 80% of their weight loss. Among those who stopped, fewer than 2 in 10 did.
And it isn’t only the scale. In the STEP 1 extension, the improvements in cardiometabolic markers — the blood pressure, the lipids, the blood sugar numbers — drifted back toward where they started as the weight returned.
Why it happens.
Two forces, both real, both pushing the same direction.
Appetite goes back to where it was
The medication doesn’t retrain your appetite permanently. It supplies a signal while it’s present. Remove it and the signalling returns to its previous setting, which means hunger returns and the food noise comes back with it. Many people describe this as the most disorienting part — not gradual, more like a switch flipping back on. If you want the mechanism in full, we cover it in our explainer on how a GLP-1 works.
A smaller body needs less fuel
This one is unavoidable physics. Carrying less weight means burning fewer calories doing everything — walking, standing, existing. So the intake that maintained you before you lost weight will now put weight back on. Return to old eating patterns in a lighter body and you’re in a surplus you weren’t in before.
Stack those together and the regain isn’t a mystery, or a personal failure. It’s the predictable result of removing a support without replacing what it was doing.
Regain isn’t evidence you did it wrong. It’s evidence the condition was real the whole time.
The part the headlines skip.
“You gain it all back” makes a better headline than what the data actually says. Three things get lost.
- The averages hide enormous variation. In the STEP 1 extension, nearly half the semaglutide group still had 5% or more weight loss a full year after stopping. That’s a clinically meaningful result, and it’s invisible in a headline about mean regain.
- How much you regain matters, not just whether you do. A later analysis of SURMOUNT-4 grouped people by how much they’d regained. Those who put back less than a quarter of their loss largely held onto their cardiometabolic improvements. The more weight came back, the more those gains reversed. Partial maintenance is not failure — it’s a real health outcome.
- The trials removed the support programme too. In the STEP 1 extension, participants stopped the drug and the structured lifestyle intervention at the same time. That’s a clean experiment, but it isn’t how a thoughtful transition would be handled in practice.
That last point deserves care, because it’s where a lot of marketing overreaches. We can’t tell you that keeping the habits eliminates regain — there isn’t evidence for that claim, and we won’t make it. What we can say is that the trials tested stopping everything at once, and the results tell you what that scenario produces.
Why nobody says this about blood pressure.
Here’s a comparison worth holding onto.
Nobody stops a blood pressure medication that’s working, watches their blood pressure rise, and concludes the medication failed. Everyone understands the medication was managing a condition rather than curing it, and removing it lets the condition reassert itself.
Obesity behaves the same way. It’s a chronic, relapsing condition with strong biological drivers. The researchers behind these withdrawal trials say so explicitly in their conclusions.
We raise this because of the shame attached. Women tell us they regained after a previous attempt and describe it as proof they’re incapable. They’re describing normal physiology in a body that was doing exactly what bodies do.
What actually changes your odds.
You have less control than the internet promises, and more than the trial averages suggest. Four things carry real weight.
The muscle you kept on the way down
This is the big one, and it’s decided long before you stop. Lose weight fast with no attention to protein or resistance training and a meaningful share comes from lean tissue — which lowers your energy requirement further and makes maintenance harder in a lighter body. Protect muscle on the way down and you arrive at your goal weight with a metabolism that can defend it.
Whether the habits are actually habits
Not intentions. Behaviours you’ve been doing for months without deciding to. If your protein target only worked because appetite suppression made it easy, it isn’t established yet. If you’ve been strength training twice a week for six months, that one probably is.
Whether you taper or just stop
An abrupt stop means appetite returns all at once, with no time to adjust. A planned reduction — and whether that’s appropriate for you is a physician’s call, not ours — gives you a runway to notice hunger returning and respond deliberately instead of reactively.
Whether stopping was the goal in the first place
Plenty of people continue at a maintenance dose long term, the way they’d continue any medication managing a chronic condition. That’s a legitimate outcome, not a defeat. Our prescriptions are valid for twelve months and nothing auto-renews, so continuing is a decision you make rather than one that happens to you — we spell out how that works on the 90-Day Transformation page.
Where our lane ends. Whether to stop, taper, or continue — and on what schedule — is a medical decision for your prescribing physician, who knows your history. As dietitians we handle the nutrition and training side of the transition. We don’t give dosing guidance here or by message.
If you’re planning to stop.
Some practical ground to cover, ideally well before your last dose.
- Talk to your physician first. Obvious, routinely skipped. Have the conversation about timing rather than deciding alone.
- Audit your protein honestly. If you’ve been hitting your target only because you weren’t hungry, appetite returning will expose that fast. Build the habit while it’s still easy.
- Get the strength training established. Two sessions a week, already routine, before appetite comes back — not something you plan to start afterward.
- Decide what you’ll measure. Weekly weight, or waist, or how clothes fit. Small regain caught early is a small correction. Six months of not looking is a different problem.
- Expect hunger and plan for it. It isn’t willpower failing. It’s the signal returning, exactly as it should.
The habits and targets we build around all of this are the same ones in our best-practice guides, and the short supplement list that supports them is here.
The medication is the runway. What you build on it decides the landing.
Questions we get
About stopping a GLP-1.
On average people regain a substantial portion, but not universally all of it. In the STEP 1 extension, participants regained about two-thirds of their loss over a year off treatment and remained 5.6% below their starting weight, with nearly half still holding 5% or more loss. Individual outcomes vary widely, and how much you preserved of your muscle and habits during the losing phase appears to matter.
No, and that decision is yours with your physician. Some people continue at a maintenance dose the way they would any medication for a chronic condition. Others taper off and manage with nutrition and training. Both are legitimate. What the evidence argues against is stopping abruptly with no plan for what replaces the support.
Gradually rather than overnight. In the withdrawal trials, regain accumulated steadily across the year following discontinuation rather than arriving in a rush. Appetite tends to return sooner than the weight does, which is why the first few weeks off treatment are worth paying close attention to.
We won't promise that, because the evidence doesn't support it. What we can say is that the trials withdrew the medication and the structured lifestyle programme at the same time, so they describe a scenario where all support is removed at once. Preserved muscle and established habits reasonably improve your position, but no nutrition plan makes regain impossible.
Yes, and it's common. In SURMOUNT-4 the group that continued treatment not only avoided regain but lost modestly more. Whether a maintenance approach suits you, and at what dose, is a conversation for your prescribing physician, who can weigh your history and how you've responded.
You're describing the most common story we hear, and it isn't a character problem. It's what happens when a prescription arrives without a plan attached. Starting again with muscle protection and a real structure in place is a meaningfully different attempt from the first one.